Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Cipla
Citi
Harvard Business School
Cerilliant
Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald

Generated: May 21, 2018

DrugPatentWatch Database Preview

Moexipril hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for moexipril hydrochloride and what is the scope of moexipril hydrochloride freedom to operate?

Moexipril hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Chartwell Rx, Glenmark Generics, Teva, and Ucb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for moexipril hydrochloride. Six suppliers are listed for this compound.
Pharmacology for moexipril hydrochloride
Synonyms for moexipril hydrochloride
(3S)-2-((2S)-N-((1S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
(S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid hydrochloride
3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
3-isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-(2-((1-ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
586M525
82586-52-5
AB2000483
AC1L1HXF
AKOS016340373
Ambap103775-10-6
AN-36120
API0003416
BS-1007
C27H34N2O7.HCl
CAS-82586-52-5
CHEBI:6961
CHEMBL1200534
CI 925
CI-925
CS-2446
CTK8G1159
D00623
DSSTox_CID_24267
DSSTox_GSID_44267
DSSTox_RID_80137
DTXSID7044267
Femipres
HY-B0378A
JXRAXHBVZQZSIC-JKVLGAQCSA-N
LS-85469
MLS003882580
Moexipril (hydrochloride)
Moexipril HCL
Moexipril hydrochloride (USAN)
Moexipril hydrochloride [USAN]
Moexipril hydrochloride, powder, >=98% (HPLC)
Moexipril hydrochloride, United States Pharmacopeia (USP) Reference Standard
MolPort-003-666-743
NCGC00167834-01
NCGC00263546-01
Perdix
Primoxil
Q1UMG3UH45
RS 10085
RS 10085-197
RS-10085
RS-10085-197
s2079
SC-95143
SCHEMBL40877
SMR002533645
SPM 925
SPM-925
Tox21_112590
Tox21_112590_1
UNII-Q1UMG3UH45
Univasc
Univasc (TN)

US Patents and Regulatory Information for moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 077536-001 Nov 30, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454-001 Jun 2, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Chartwell Rx MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 077536-002 Nov 30, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 076204-001 May 8, 2003 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Cipla
UBS
Merck
Moodys
Cerilliant
Accenture
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.